Behçet Disease News

News

Biologic May Be a Viable Option for Patients with Behçet Disease

05/13/2020

Findings from a recent prospective study showed patients with Behçet disease treated with a biologic agent experienced significant improvements in arthritis and mucocutaneous manifestations.

Findings from a recent...

05/13/2020

Autoimmune

Popular Articles

News

FLARE Questionnaire for PsA Demonstrates Validity

10/15/2021

Patients with psoriatic arthritis report most common symptoms as musculoskeletal pain and fatigue, new research reports.

Patients with psoriatic...

10/15/2021

Rheumatology & Arthritis

News

SLE Disease Flare Less Likely With HCQ Maintenance

01/06/2022

Patients with systemic lupus erythematosus were more likely to experience a flare following hydroxychloroquine (HCQ) taper/discontinuation when compared to patients on HCQ maintenance.

Patients with systemic lupus...

01/06/2022

Autoimmune

News

FDA Grants Orphan Drug Designation to Efzofitimod for Systemic Sclerosis

04/19/2022

The new immunomodulator outperformed existing antifibrotic agents in animal models.

The new immunomodulator...

04/19/2022

Rheumatology & Arthritis

Conference Coverage

Gil Melmed, MD, on COVID-19 Vaccination Responses and Safety in Patients with IBD

12/21/2022

Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.

Dr Melmed reviews the results of...

12/21/2022

Autoimmune

News

Can IL-17 and IL-12/23 Help When TNFi Can’t?

12/29/2022

A new study indicates that patients with psoriasis and psoriatic arthritis who fail to respond to TNFi treatment may experience improvement with IL-17 and IL-12/23 inhibitors.

A new study indicates that...

12/29/2022

Rheumatology & Arthritis

Stay In the Know

Autoimmune Newsletter

Behçet Disease News

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products